Results 201 to 210 of about 72,792 (263)

Odz4 upregulates SAN-specific genes to promote differentiation into cardiac pacemaker-like cells. [PDF]

FEBS Lett
Dong A, Yoshizumi M, Kokubo H.
europepmc   +1 more source

Utilization and Prognosis of Cardiac Device Implantation in AL Versus ATTR Amyloidosis

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Cardiac amyloidosis can cause congestive heart failure, arrhythmias, and heart blocks, which frequently require cardiac device implantation (CDI). However, the differences between light chain (AL) amyloidosis and transthyretin (ATTR) amyloidosis CDI requirements are unknown. Methods A retrospective analysis was conducted using the
Bilal Hussain, Sanchit Duhan, Khawaja Hassan Akhtar, Amith Reddy Seri, Krittapoom Akrawinthawong, Janardhana Gorthi, Bijeta Keisham, Tarun Dasari   +7 more
wiley   +1 more source

Types of Complications and Associated Factors in Patients Undergoing Permanent Cardiac Pacemaker Implantation: A Systematic Review. [PDF]

J Multidiscip Healthc
Sugiharto F, Asmara AD, Sari WP, Freitas LA, Ramdani D, Anna A, Nuraeni A, Trisyani Y, Purnomo Y.   +8 more
europepmc   +1 more source

Early Mobilization After Pacemaker Implantation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The increasing use of cardiac implantable electronic devices (CIED) is leading to a rise in procedure‐related complications. Objective This trial aimed to assess the safety and feasibility of early mobilization and the possibility of same‐day discharge following permanent pacemaker implantation.
Jiří Šmíd, Vlastimil Vančura, Martin Brada, Richard Rokyta   +3 more
wiley   +1 more source

Baseline and changes in prognostic nutritional index associate with heart failure hospitalization and all-cause death in patients with cardiac pacemaker. [PDF]

BMC Cardiovasc Disord
Zhang J, Yao H, Lu Y, Lian L, Zheng R, Chen C.   +5 more
europepmc   +1 more source

Cardiac Pacemaker-Apparently Disconnected. [PDF]

Dtsch Arztebl Int, 2020
Ohlow MA.
europepmc   +1 more source

Impact of Leadless Pacemaker Implantation Position on Subclinical Right Ventricular Perforation

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Introduction Leadless pacemakers are typically implanted in the mid‐septum of the right ventricle (RV) to mitigate the risk of perforation. However, reports on the precise location of these implants are limited. This study aimed to elucidate tine‐based leadless pacemaker position and presence of subclinical RV perforation through computed ...
Young Shin Lee, Jae‐Sun Uhm, Je‐Wook Park, Seung‐Jung Park, Ye Chan Kim, In‐Soo Kim, Hye‐Jeong Lee, Moon‐Hyun Kim, Hanjin Park, Daehoon Kim, Hee Tae Yu, Tae‐Hoon Kim, Jin‐Bae Kim, Jong‐Youn Kim, Boyoung Joung, Hui‐Nam Pak, Moon‐Hyoung Lee   +16 more
wiley   +1 more source

Permanent Artificial Cardiac Pacemaker in the Treatment of Bradyarrhythmias Caused by Chagas Disease. [PDF]

Arq Bras Cardiol
Costa R.
europepmc   +1 more source

Ca²⁺/Calmodulin-Dependent Protein Kinase II (CaMKII) Regulates Basal Cardiac Pacemaker Function: Pros and Cons. [PDF]

Cells
Vinogradova TM, Lakatta EG.
europepmc   +1 more source

Jugular Versus Femoral Venous Access for Leadless Pacemaker Implantation: A Systematic Review and Meta‐Analysis

Pacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background Leadless pacemakers (LPMs) have been shown to reduce complications compared with conventional transvenous pacing. Transfemoral venous access (FA) is the standard implantation approach; however, the transjugular approach (JA) has recently emerged as an alternative strategy, but comparative evidence remains limited.
Federico Giannino, Giampaolo Vetta, Carlo Cardì, Rodolfo Caminiti, Pasquale Crea, Giuseppe Dattilo, Riccardo Sbriglione, Luciana Lombardo, Giovanni Coluccia, Pietro Palmisano, Rosario Foti, Antonio Parlavecchio   +11 more
wiley   +1 more source